Scarica l'app Stockscreener
90.20
2.13%
-1.96
Dopo l'orario di chiusura:
92.90
2.70
+2.99%
Precedente Chiudi:
$92.16
Aprire:
$91.7
Volume 24 ore:
742.94K
Relative Volume:
0.43
Capitalizzazione di mercato:
$5.44B
Reddito:
-
Utile/perdita netta:
$-116.25M
Rapporto P/E:
-37.72
EPS:
-2.3912
Flusso di cassa netto:
$-91.19M
1 W Prestazione:
-1.65%
1M Prestazione:
-0.44%
6M Prestazione:
+158.45%
1 anno Prestazione:
+532.98%
Intervallo 1D:
$89.37
$93.50
Intervallo di 1 settimana:
$89.37
$96.00
Portata 52W:
$12.84
$97.78
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Compare ORKA vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
90.20 | 5.56B | 0 | -116.25M | -91.19M | -2.3912 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-18 | Iniziato | Piper Sandler | Overweight |
| 2025-11-13 | Iniziato | Jefferies | Buy |
| 2025-10-27 | Iniziato | Guggenheim | Buy |
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Oruka Therapeutics Inc (ORKA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oruka Therapeutics Inc (ORKA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
ORKA|Oruka Therapeutics Inc|Price:92.160|Chg%:+0.210 - TradingKey
Oruka Therapeutics, Inc. Revenue Breakdown – NASDAQ:ORKA - TradingView
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Oruka Therapeutics Inc (ORKA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oruka Therapeutics Inc. (ORKA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
ORKA Stock Climbs As Traders Track Tight Range - StocksToTrade
ORKA Stock Grinds Higher As Traders Track Tight Range - timothysykes.com
ORKA Stock Climbs As Traders Track Strong Cash Runway - StocksToTrade
Oruka Therapeutics Rises as Investors Focus on Pipeline Data Setup - Quiver Quantitative
Form 144 ORUKA THERAPEUTICS INC For: 15 July By Investing.com - Investing.com Australia
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares - Investing.com UK
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com - Investing.com Nigeria
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 15 July - Investing.com UK
Form 144 ORUKA THERAPEUTICS INC For: 15 July - Investing.com UK
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $151 - Moomoo
Form 4 Oruka Therapeutics Inc For: 13 July By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP sells $846k in stock By Investing.com - Investing.com Nigeria
Form 144 Oruka Therapeutics For: 13 July By Investing.com - Investing.com Australia
Oruka Therapeutics Insider Sold Shares Worth $846,180, According to a Recent SEC Filing - Moomoo
Oruka Therapeutics SVP sells $846k in stock - Investing.com
Form 144 Oruka Therapeutics For: 13 July - Investing.com UK
Oruka TherapeuticsIntriguing Long Acting Psoriasis Programs May Need Further Derisking - Seeking Alpha
How Investors May Respond To Oruka Therapeutics (ORKA) Russell Index Shift Toward Small-Cap Growth Benchmarks - simplywall.st
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares - MSN
Oruka Therapeutics (ORKA) Holds Steady Near Resistance Amid Low VolatilityOption Breadth - dars.gov.et
Oruka Therapeutics (ORKA) Recast By Russell Growth Shift On A Valuation That Looks About Right - Sahm
Why Oruka Therapeutics (ORKA) Is Up 13.6% After Russell Index Reclassification Into Growth Benchmarks - Sahm
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics (ORKA) Sees 8.1% Decline - GuruFocus
Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing - marketscreener.com
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock By Investing.com - Investing.com India
Form 144 | Oruka Therapeutics(ORKA.US) Insider Proposes to Sell 300.01 Million in Common Stocks - Moomoo
Insider Sell: Laura Sandler Sells 5,000 Shares of Oruka Therapeu - GuruFocus
Form 144 Oruka Therapeutics For: 1 July By Investing.com - Investing.com Nigeria
Form 13D/A ORUKA THERAPEUTICS For: 1 July By Investing.com - Investing.com Nigeria
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock - Investing.com
Form 144 Oruka Therapeutics For: 1 July - Investing.com UK
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):